Printer Friendly

Firm nears completion of human genome.

Forget about those Internet companies. Instead, take a look at the skyrocketing stock price of Celera Genomics, a biotech firm in Rockville, Md., that is racing to sequence the human genome a year or two before the government-funded international effort does (SN: 5/23/98, p. 334). Celera's stock received its latest boost Jan. 10 when the company announced that it has sequenced 90 percent of the human genome and claimed it has found about 97 percent of all human genes.

Since Celera didn't release its data publicly and has yet to submit them to a scientific journal, those impressive claims remain difficult to verify. J. Craig Venter, scientific founder of Celera, acknowledges that the firm has assembled the complete DNA sequence of only a small number of genes. Celera's controversial genome strategy quickly produces sequences of gene fragments, but scientists must then use overlapping sequences to piece together the genome. Celera will continue sequencing the bits of human DNA for a few months before the complex assembly process begins in full. "We will definitely be able to finish the genome this year," asserts Venter.
COPYRIGHT 2000 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2000, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Celera Genomics
Comment:Firm nears completion of human genome.(Celera Genomics)
Publication:Science News
Article Type:Brief Article
Geographic Code:1USA
Date:Jan 29, 2000
Previous Article:Poor glucose metabolism risks clots.
Next Article:Impotence high after prostate removal.

Related Articles
Shotgun approach bags the fruit fly genome.
Genes, genes, and more genes.
Human Genome Work Reaches Milestone.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |